Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-28 Sale | 2024-02-29 4:18 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 574 | $155.3 | $89,145 | 23,351 (Indirect Direct) | View |
| 2024-02-16 Sale | 2024-02-20 4:08 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,007 | $148.06 | $149,099 | 18,201 (Indirect Direct) | View |
| 2023-08-04 Sale | 2023-08-07 6:05 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,460 | $185.85 | $643,037 | 15,930 (Indirect Direct) | View |
| 2023-04-27 Sale | 2023-04-28 5:55 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 977 | $194.59 | $190,113 | 11,763 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 4:21 pm | N/A 2034-03-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 22,859 | $0 | 42,394 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-29 4:18 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 23,351 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:08 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,278 | $0 | 18,201 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-15 6:52 pm | N/A 2033-09-15 | CervoMed Inc. | CRVO | Poulton Jeffrey V. Director | 6,450 | $0 | 6,450 (Direct) | View |
Ownership | 2023-08-23 9:48 pm | N/A 2028-05-29 | CervoMed Inc. | CRVO | Poulton Jeffrey V. Director | 0 | $0 | 14,963 (Direct) | View |
| 2023-08-03 Option Award | 2023-08-07 6:05 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 7,627 | $0 | 15,930 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 6:09 pm | N/A 2033-06-14 | Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 5:55 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,277 | $0 | 11,763 (Direct) | View |
| 2023-02-27 Option Award | 2023-03-01 4:21 pm | N/A 2026-02-27 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 17,574 | $0 | 17,574 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 146 | $209.88 | 9,463 (Direct) | View |
| 2022-08-03 Option Award | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 11,325 | $0 | 9,463 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 4,573 | $189.76 | 9,463 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 173 | $210.5 | 9,463 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-05 4:14 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 162 | $209.83 | 9,463 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:05 pm | N/A 2032-06-15 | Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:12 pm | N/A 2032-02-22 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 18,413 | $0 | 18,413 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 5:39 pm | N/A 2031-06-17 | Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 6:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 4,518 | $0 | 3,211 (Direct) | View |
| 2021-04-20 Tax Withholding | 2021-04-21 6:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 1,333 | $131.75 | 3,211 (Direct) | View |
| 2021-04-20 Tax Withholding | 2021-04-21 6:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 50 | $134.49 | 3,211 (Direct) | View |
| 2019-10-10 Other | 2021-04-21 6:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 38 | $0 | 3,211 (Indirect) | View |
| 2021-02-24 Option Award | 2021-02-26 4:04 pm | N/A 2031-02-23 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 23,200 | $0 | 23,200 (Direct) | View |
| 2020-07-21 Option Award | 2020-07-21 5:31 pm | N/A 2030-07-20 | Homology Medicines Inc. | FIXX | Poulton Jeffrey V. Director | 36,000 | $0 | 36,000 (Direct) | View |
| 2020-02-26 Option Award | 2020-02-28 4:07 pm | N/A 2030-02-25 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 24,554 | $118.05 | 24,592 (Direct) | View |
| 2020-01-03 Other | 2020-02-28 4:07 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 19 | $0 | 24,592 (Indirect) | View |
Ownership | 2019-08-13 4:09 pm | N/A 2029-07-31 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. Chief Financial Officer | 0 | $0 | 125,000 (Direct) | View |